Ceryvyn Therapeutics (OPTEY) Stock Price, News & Analysis
Company Description
Ceryvyn Therapeutics (OTC Link: OPTEY) is a publicly traded company.
OPTEY stock has declined 85.8% over the past year. Shares last traded at $0.0214.
On a trailing twelve-month basis, Ceryvyn Therapeutics reported revenue of $25K with net income of -$162.8M. The company operates at a net profit margin of -651164.0%.
This page provides a comprehensive overview of OPTEY stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ceryvyn Therapeutics (OPTEY) stock last traded at $0.0214. Over the past 12 months, the stock has lost 85.8%.
OPTEY Rankings
Latest News
SEC Filings
Ceryvyn Therapeutics has filed 1 recent SEC filing, including 1 Form SCHEDULE 13G/A. The most recent filing was submitted on July 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OPTEY SEC filings →
Financial Highlights
Ceryvyn Therapeutics generated $25K in revenue over the trailing twelve months, and net income was -$162.8M, reflecting a -651164.0% net profit margin. The company generated -$158.6M in operating cash flow. With a current ratio of 0.22, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Ceryvyn Therapeutics (OPTEY) currently stands at 9.8 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 60.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Ceryvyn Therapeutics (OPTEY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.7 days.